UNLABELLED: Abstract Background: The diversity of the U.S. population and disparities in the burden of cardiovascular disease (CVD) require that public health education strategies must target women and racial/ethnic minority groups to reduce their CVD risk factors, particularly in high-risk communities, such as women with the metabolic syndrome (MS). METHODS: The data reported here were based on a cross-sectional face-to-face survey of women recruited from four participating sites as part of the national intervention program, Improving, Enhancing and Evaluating Outcomes of Comprehensive Heart Care in High-Risk Women. Measures included baseline characteristics, sociodemographics, CVD related-knowledge and awareness, and Framingham risk score (FRS). RESULTS: There were 443 of 698 women (63.5%) with one or more risk factors for the MS: non-Hispanic white (NHW), 51.5%; non-Hispanic black (NHB), 21.0%; Hispanic, 22.6%. Greater frequencies of MS occurred among Hispanic women (p<0.0001), those with less than a high school education (70.0%) (p<0.0001), Medicaid recipients (57.8%) (p<0.0001), and urbanites (43.3%) (p<0.001). Fewer participants with MS (62.6%) knew the leading cause of death compared to those without MS (72.1%) (p<0.0001). MS was associated with a lack of knowledge of the composite of knowing the symptoms of a heart attack plus the need to call 911 (odds ratio [OR] 0.41, 95% confidence interval [CI] 0.17-0.97, p=0.04). CONCLUSIONS: Current strategies to decrease CVD risk are built on educating the public about traditional factors, including hypertension, smoking, and elevated low-density lipoprotein cholesterol (LDL-C). An opportunity to broaden the scope for risk reduction among women with cardiometabolic risk derives from the observation that women with the MS have lower knowledge about CVD as the leading cause of death, the symptoms of a heart attack, and the ideal option for managing a CVD emergency.
UNLABELLED: Abstract Background: The diversity of the U.S. population and disparities in the burden of cardiovascular disease (CVD) require that public health education strategies must target women and racial/ethnic minority groups to reduce their CVD risk factors, particularly in high-risk communities, such as women with the metabolic syndrome (MS). METHODS: The data reported here were based on a cross-sectional face-to-face survey of women recruited from four participating sites as part of the national intervention program, Improving, Enhancing and Evaluating Outcomes of Comprehensive Heart Care in High-Risk Women. Measures included baseline characteristics, sociodemographics, CVD related-knowledge and awareness, and Framingham risk score (FRS). RESULTS: There were 443 of 698 women (63.5%) with one or more risk factors for the MS: non-Hispanic white (NHW), 51.5%; non-Hispanic black (NHB), 21.0%; Hispanic, 22.6%. Greater frequencies of MS occurred among Hispanic women (p<0.0001), those with less than a high school education (70.0%) (p<0.0001), Medicaid recipients (57.8%) (p<0.0001), and urbanites (43.3%) (p<0.001). Fewer participants with MS (62.6%) knew the leading cause of death compared to those without MS (72.1%) (p<0.0001). MS was associated with a lack of knowledge of the composite of knowing the symptoms of a heart attack plus the need to call 911 (odds ratio [OR] 0.41, 95% confidence interval [CI] 0.17-0.97, p=0.04). CONCLUSIONS: Current strategies to decrease CVD risk are built on educating the public about traditional factors, including hypertension, smoking, and elevated low-density lipoprotein cholesterol (LDL-C). An opportunity to broaden the scope for risk reduction among women with cardiometabolic risk derives from the observation that women with the MS have lower knowledge about CVD as the leading cause of death, the symptoms of a heart attack, and the ideal option for managing a CVD emergency.
Authors: Yong-Woo Park; Shankuan Zhu; Latha Palaniappan; Stanley Heshka; Mercedes R Carnethon; Steven B Heymsfield Journal: Arch Intern Med Date: 2003-02-24
Authors: David C Goff; Paul Mitchell; John Finnegan; Dilip Pandey; Vera Bittner; Henry Feldman; Hendrika Meischke; Robert J Goldberg; Russell V Luepker; James M Raczynski; Lawton Cooper; Clay Mann Journal: Prev Med Date: 2004-01 Impact factor: 4.018
Authors: Lynn Rosenberg; Julie R Palmer; Lauren A Wise; Nicholas J Horton; Shiriki K Kumanyika; Lucile L Adams-Campbell Journal: Obes Res Date: 2003-12
Authors: Jacob A Udell; Gregg C Fonarow; Thomas M Maddox; Christopher P Cannon; W Frank Peacock; Warren K Laskey; Maria V Grau-Sepulveda; Eric E Smith; Adrian F Hernandez; Eric D Peterson; Deepak L Bhatt Journal: Clin Cardiol Date: 2018-05-11 Impact factor: 2.882
Authors: Elsa-Grace V Giardina; Lorraine Mull; Robert R Sciacca; Sharon Akabas; Laura E Flink; Nathalie Moise; Tracy K Paul; Nicole E Dumas; Michael L Bier; Deirdre Mattina Journal: Clin Cardiol Date: 2011-11-14 Impact factor: 2.882
Authors: Laura E Flink; Robert R Sciacca; Michael L Bier; Juviza Rodriguez; Elsa-Grace V Giardina Journal: Clin Cardiol Date: 2013-01-21 Impact factor: 2.882
Authors: Qun Wang; Sek Ying Chair; Eliza Mi-Ling Wong; Ruth E Taylor-Piliae; Xi Chen Hui Qiu; Xiao Mei Li Journal: Int J Environ Res Public Health Date: 2019-01-08 Impact factor: 3.390
Authors: LaPrincess C Brewer; Sharonne N Hayes; Amber R Caron; David A Derby; Nicholas S Breutzman; Amy Wicks; Jeyakumar Raman; Christina M Smith; Karen S Schaepe; Ruth E Sheets; Sarah M Jenkins; Kandace A Lackore; Jacqueline Johnson; Clarence Jones; Carmen Radecki Breitkopf; Lisa A Cooper; Christi A Patten Journal: PLoS One Date: 2019-08-20 Impact factor: 3.240